GE HealthCare has announced the Food and Drug Administration (FDA) 510 (k) clearance for its SIGNA MAGNUS magnetic resonance ...

Clinical Trial Imaging Services Market, valued at USD 1.31 billion in 2023, is expected to grow at a compound annual growth rate of 5.4 ...

Facility uses cutting-edge tech that changes how metabolic health is assessed and its impact on heart disease. Read more at ...

Wei Bao, Ph.D., assistant professor in the Department of Materials Science and Engineering at Rensselaer Polytechnic ...

A study found that ketamine, which causes dissociation, did not increase emotional suppression in PTSD patients. Instead, it ...

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.

In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

In alignment with Egypt's Vision 2030 for healthcare and based on the directives of President Abdel-Fattah El-Sisi and as ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report) today. The company’s shares ...

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...

A team of researchers has developed a technique for diagnosing, managing and treating neurological disorders with minimal surgical risks.